Effect of interleukin 1β inhibition in cardiovascular disease.

@article{Qamar2012EffectOI,
  title={Effect of interleukin 1β inhibition in cardiovascular disease.},
  author={Arman Qamar and Daniel J. Rader},
  journal={Current opinion in lipidology},
  year={2012},
  volume={23 6},
  pages={548-53}
}
PURPOSE OF REVIEW Atherosclerosis is greatly influenced by inflammatory mediators at all phases. Recent studies have suggested a causal role of one such mediator, interleukin 1β (IL-1β), in the development of atherosclerotic vascular disease. This review highlights recent investigation of the role of IL-1β in atherosclerosis and the potential of its inhibition as a promising therapeutic strategy for the treatment of atherosclerotic vascular disease. RECENT FINDINGS Studies in animals have… CONTINUE READING